Brevetti EPO No.3755339 2024.01.03
Brevetti EPO
(10) Registration Number and Date
2024000112 2024.03.18
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2024/000112 2019.02.20
(40) Publication Number and Date
SM /T/2024/000112 2024.03.18
(30) Priority Details
EP 18305177
2018.02.20
(71/73) Applicant
(IT) UNIVERSITE DE BORDEAUX : 35, Place Pey Berland, 33000 Bordeaux, FR
(IT) AELIS FARMA : 1 rue Lafaurie de Monbadon, 33000 Bordeaux, FR
(72) Inventor
(IT) BUSQUET-GARCIA, Arnau : Neurocentre MagendieINSERM U1215146, rue Léo Saignat, 33077 Bordeaux, FR
(IT) METNA, Mathilde : c/o Aelis FarmaNeurocentre Magendie146, rue Léo Saignat, 33077 Bordeaux, FR
(IT) MONLEZUN, Stéphanie : c/o Aelis FarmaNeurocentre Magendie146, rue Léo Saignat, 33077 Bordeaux, FR
(IT) VALLÉE, Monique : Neurocentre MagendieINSERM U1215146, rue Léo Saignat, 33077 Bordeaux, FR
(74) Representative Name
(IT) MONTEBELLI, Marco : Piazza E. Enriquez, 22c, 47891 Dogana RSM, SM
(54) Title
(IT) 3-BETA-(4-METOSSIBENZILOSSI)PREGN-5-EN-20-ONE PER L'USO NEL TRATTAMENTO DI DISTURBI CORRELATI AI CANNABINOIDI
(EN) 3-BETA-(4-METHOXYBENZYLOXY)PREGN-5-EN-20-ONE FOR USE IN THE TREATMENT OF CANNABINOIDS-RELATED DISORDERS
(57) Abstract
(58) Citations